including non-small-cell lung cancer (NSCLC), breast cancer, pancreatic cancer and head and neck squamous cell carcinomas. Dragonfly's TriNKET compounds are designed to activate and direct NK and ...
Dragonfly has an ongoing phase 1/2 clinical trial of DF6002 for patients with advanced solid tumours, which began in July 2020 after the FDA granted clearance to begin clinical trials in May.
Take a look at some of the biggest small cap stock movers. This list is updated daily and includes premarket, during market, and after hours movers. When interest rates are low, small-cap stocks ...